GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Future Policy Benefits

BerGenBio ASA (OSL:BGBIO) Future Policy Benefits


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


BerGenBio ASA Business Description

Traded in Other Exchanges
Address
Nygardsgaten 114, Bergen, NOR, 5008
BerGenBio ASA is a clinical-stage biopharmaceutical company developing drugs for aggressive diseases, including drug resistant and metastatic cancers and respiratory disease. Its product, bemcentinib (BGB324), is a selective, potent, oral small molecule AXL inhibitor that has been tested in a various indications including NSCLC, AML and severe respiratory infections.